510(k) device
Ekso (version 1.1) and Ekso GT (version 1.2)
Ekso Bionics, Inc. · Powered Exoskeleton (PHL, Class II) · First FDA decision Apr 1, 2016, newest Jul 19, 2016Mobility impairmentSpinal cord injury and paralysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
45
Naming "Ekso"
MAUDE reports
5
Brand "Ekso", since 2015
PubMed studies
63
Mentioning "Ekso"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ekso (version 1.1) and Ekso GT (version 1.2)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K161443 · Decided Jul 19, 2016 · 55 days after receipt
Device type: Powered Exoskeleton (PHL) · Physical Medicine & Rehabilitation
K143690 · Decided Apr 1, 2016 · 464 days after receipt
Device type: Powered Exoskeleton (PHL) · Physical Medicine & Rehabilitation
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ekso", any status and sponsor, newest update first.
The State Academy of Applied Sciences in KoszalinAcademic, hospital or other
NCT07499063 · 25 participants · Start May 10, 2026 · Primary completion Jun 1, 2026
Device: Ekso NR Exoskeleton · For: Gait Analysis in Healthy Subjects
Sites: Koszalin, Poland
- EKSO Trial: Powered Exoskeleton for Ambulation in Subjects With Spinal Cord Injury (SCI)Active, not recruiting
Shirley Ryan AbilityLabAcademic, hospital or other
NCT01701388 · 40 participants (planned) · Start May 2012 · Primary completion Dec 31, 2027
Device: Ekso exoskeleton · For: Spinal Cord Injuries or Similar Neurological Weakness
Sites: Chicago, Illinois
IRCCS San Raffaele RomaAcademic, hospital or other
NCT07884591 · 74 participants · Start Sep 1, 2024 · Primary completion May 15, 2025
Device: Wearable Powered Exoskeleton · For: Spinal Cord Injuries (SCI); Muscle Spasticity as a Result of Spinal Cord Injury; Rehabilitation and 1 more
Sites: Roma, Italy
42 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ekso", and for the whole product code for context.
This brand
5 reports: 3 malfunction, 2 injury, 0 death
Whole product code PHL
57 reports: 7 malfunction, 50 injury, 0 death
Newest reports for this brand
MW5112195 · Received Sep 21, 2022 · Event dated Aug 22, 2022
Device type: Powered Exoskeleton (PHL)
Device problem as coded: Unexpected Therapeutic Results
Patient problem as coded: Bone Fracture(s); Sleep Dysfunction; Cramp(s) /Muscle Spasm(s); Swelling/ Edema
- EKSOInjury
3009495988-2018-00001 · Received Oct 2, 2018 · Event dated May 15, 2018
Device type: Powered Exoskeleton (PHL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bone Fracture(s); Joint Swelling
- EKSOMalfunction
7572849 · Received Jun 6, 2018 · Event dated May 15, 2018
Device type: Powered Exoskeleton (PHL)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Edema; Swelling; Spinal Cord Injury
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Ekso"[tiab]. The summary above synthesizes these.
- Feasibility of integrating robotic exoskeleton gait training in inpatient rehabilitation.
Swank C, Sikka S, Driver S, et al. · Disabil Rehabil Assist Technol · 2020
- Immediate kinematic and muscle activity changes after a single robotic exoskeleton walking session post-stroke.
Swank C, Almutairi S, Wang-Price S, et al. · Top Stroke Rehabil · 2020Research Support, Non-U.S. Gov't
- Walking improvement in chronic incomplete spinal cord injury with exoskeleton robotic training (WISE): a randomized controlled trial.
Edwards DJ, Forrest G, Cortes M, et al. · Spinal Cord · 2022Randomized Controlled Trial
- Brain Network Organization Following Post-Stroke Neurorehabilitation.
Naro A, Pignolo L, Calabrò RS · Int J Neural Syst · 2022
- "Back at the same level as everyone else"-user perspectives on walking with an exoskeleton, a qualitative study.
Thomassen GK, Jørgensen V, Normann B · Spinal Cord Ser Cases · 2019
- Walking With a Robotic Exoskeleton Does Not Mimic Natural Gait: A Within-Subjects Study.
Swank C, Wang-Price S, Gao F, et al. · JMIR Rehabil Assist Technol · 2019
- User satisfaction with lower limb wearable robotic exoskeletons.
Poritz JMP, Taylor HB, Francisco G, et al. · Disabil Rehabil Assist Technol · 2020Comparative Study, Research Support, Non-U.S. Gov't
- Overground walking with a robotic exoskeleton elicits trunk muscle activity in people with high-thoracic motor-complete spinal cord injury.
Alamro RA, Chisholm AE, Williams AMM, et al. · J Neuroeng Rehabil · 2018Research Support, Non-U.S. Gov't
- Preparing epoxidized vegetable oil from waste generated by the kapok fiber industry and assessing its thermal stabilization effect as a co-stabilizer for polyvinyl chloride.
Putrawan IDGA, Azharuddin A, Jumrawati J · Heliyon · 2023
- Implementing the exoskeleton Ekso GTTM for gait rehabilitation in a stroke unit - feasibility, functional benefits and patient experiences.
Høyer E, Opheim A, Jørgensen V · Disabil Rehabil Assist Technol · 2022
- Overground vs. treadmill-based robotic gait training to improve seated balance in people with motor-complete spinal cord injury: a case report.
Chisholm AE, Alamro RA, Williams AM, et al. · J Neuroeng Rehabil · 2017Case Reports
- Wearable Robotic Gait Training in Persons with Multiple Sclerosis: A Satisfaction Study.
Fernández-Vázquez D, Cano-de-la-Cuerda R, Gor-García-Fogeda MD, et al. · Sensors (Basel) · 2021
Other devices of this type
Also filed under product code PHL.
- Indego(R)Parker-Hannifin Corporation · 510(k) 2018
- Atalante XWandercraft SAS · 510(k) 2025
- ReWalk P6.0Re Walk Robotics , Ltd. · 510(k) 2023
- EksoNREkso Bionics, Inc. · 510(k) 2022
- HAL for Medical Use(Lower Limb type)Cyberdyne, Inc. · 510(k) 2020
- Trexo TheoTrexo Robotics, Inc. · 510(k) 2026
- EveWandercraft SAS · 510(k) 2026
- ReWalk® 7 Personal Exoskeleton (50-20-0005)Rewalk Robotics Ltd. Dba Lifeward · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.